Frontera commences subject dosing in trial of gene therapy for XLRP
17 Feb 2023 //
CLINICAL TRIALS ARENA
Frontera Therapeutics Doses First Patient in a Clinical Trial of FT-003
02 Feb 2023 //
GLOBENEWSWIRE
Frontera Doses First Patient in Phase 1 Clinical Trial for Gene Therapy FT-001
06 Jan 2023 //
GLOBENEWSWIRE